Published in J Neurosci Res on May 01, 1990
Varicella-zoster virus. Clin Microbiol Rev (1996) 3.03
Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci U S A (1996) 2.71
Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J Virol (1995) 2.58
Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin (2008) 1.99
Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc Natl Acad Sci U S A (2005) 1.89
Characterization of regulatory functions of the varicella-zoster virus gene 63-encoded protein. J Virol (1992) 1.68
Review: The neurobiology of varicella zoster virus infection. Neuropathol Appl Neurobiol (2011) 1.45
Characterization of varicella-zoster virus gene 21 and 29 proteins in infected cells. J Virol (2002) 1.24
Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs. Neuroscience (2006) 1.14
Comparison of dorsal root ganglion gene expression in rat models of traumatic and HIV-associated neuropathic pain. Eur J Pain (2008) 1.12
Herpes zoster and postherpetic neuralgia: past, present and future. Pain Res Manag (2009) 1.10
Simian varicella virus pathogenesis. Curr Top Microbiol Immunol (2010) 1.08
Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol Rev (2013) 1.06
Differentiated neuroblastoma cells provide a highly efficient model for studies of productive varicella-zoster virus infection of neuronal cells. J Virol (2011) 1.01
Varicella-zoster virus proteins in skin lesions: implications for a novel role of ORF29p in chickenpox. J Virol (2000) 0.88
Postherpetic neuralgia: from preclinical models to the clinic. Neurotherapeutics (2009) 0.86
Postentry events are responsible for restriction of productive varicella-zoster virus infection in Chinese hamster ovary cells. J Virol (2006) 0.86
Clinical and molecular aspects of varicella zoster virus infection. Future Neurol (2009) 0.84
Rodent models of varicella-zoster virus neurotropism. Curr Top Microbiol Immunol (2010) 0.84
Spinal astrocytic activation is involved in a virally-induced rat model of neuropathic pain. PLoS One (2011) 0.82
Varicella Zoster Virus in the Nervous System. F1000Res (2015) 0.79
Animal models of varicella zoster virus infection. Pathogens (2013) 0.78
Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge. J Virol (2014) 0.78
Neuronal changes induced by Varicella Zoster Virus in a rat model of postherpetic neuralgia. Virology (2015) 0.78
Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited. Neurology (1996) 4.02
Specific interaction of cellular factors with the B enhancer of polyoma virus. EMBO J (1985) 3.23
The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol Cell Biol (1994) 3.16
Two different factors bind to the alpha-domain of the polyoma virus enhancer, one of which also interacts with the SV40 and c-fos enhancers. EMBO J (1987) 3.09
Baseline brain activity fluctuations predict somatosensory perception in humans. Proc Natl Acad Sci U S A (2007) 2.78
Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci U S A (1996) 2.71
TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors. EMBO J (1989) 2.65
Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells. Nature (1987) 2.65
Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J Virol (1995) 2.58
Quality of life in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study instrument. Ann Intern Med (1992) 2.40
Intrinsic brain activity in altered states of consciousness: how conscious is the default mode of brain function? Ann N Y Acad Sci (2008) 2.29
Activation of the polyomavirus enhancer by a murine activator protein 1 (AP1) homolog and two contiguous proteins. Proc Natl Acad Sci U S A (1988) 2.24
Voluntary brain processing in disorders of consciousness. Neurology (2008) 2.24
Genome microarray analysis of transcriptional activation in multidrug resistance yeast mutants. FEBS Lett (2000) 2.22
The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc Natl Acad Sci U S A (1993) 2.01
DNA sequence of the carA gene and the control region of carAB: tandem promoters, respectively controlled by arginine and the pyrimidines, regulate the synthesis of carbamoyl-phosphate synthetase in Escherichia coli K-12. Proc Natl Acad Sci U S A (1984) 1.81
Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. J Gen Intern Med (1991) 1.80
Neurotransmitters as early signals for central nervous system development. Cell Tissue Res (2001) 1.78
IS3 can function as a mobile promoter in E. coli. Nucleic Acids Res (1982) 1.75
Retinoic acid stimulates regeneration of mammalian auditory hair cells. Science (1993) 1.74
Functional connectivity in the default network during resting state is preserved in a vegetative but not in a brain dead patient. Hum Brain Mapp (2009) 1.72
Cortical processing of noxious somatosensory stimuli in the persistent vegetative state. Neuroimage (2002) 1.71
Characterization of regulatory functions of the varicella-zoster virus gene 63-encoded protein. J Virol (1992) 1.68
The regulatory region of the divergent argECBH operon in Escherichia coli K-12. Nucleic Acids Res (1982) 1.60
Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity. Mol Cell Biol (1999) 1.57
PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress. Cell Death Differ (2012) 1.57
Variation in health service use among HIV-infected patients. Med Care (1992) 1.56
When thoughts become action: an fMRI paradigm to study volitional brain activity in non-communicative brain injured patients. Neuroimage (2007) 1.54
Plasminogen activator-plasmin system and neuronal migration. Nature (1982) 1.50
Molecular basis for modulated regulation of gene expression in the arginine regulon of Escherichia coli K-12. Nucleic Acids Res (1983) 1.49
The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. Br J Pharmacol (2002) 1.45
Homologous control sites and DNA transcription starts in the related argF and argI genes of Escherichia coli K12. EMBO J (1982) 1.43
[Diagnostic exercise for the medical school student: how to analyze an abnormality of eye movements?]. Rev Med Liege (2010) 1.38
Evolutionary divergence of genes for ornithine and aspartate carbamoyl-transferases--complete sequence and mode of regulation of the Escherichia coli argF gene; comparison of argF with argI and pyrB. Nucleic Acids Res (1984) 1.37
Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stress. J Immunol (2000) 1.33
Oxidative stress-induced apoptosis of cochlear sensory cells: otoprotective strategies. Int J Dev Neurosci (2000) 1.31
Intracellular transport of the glycoproteins gE and gI of the varicella-zoster virus. gE accelerates the maturation of gI and determines its accumulation in the trans-Golgi network. J Biol Chem (1998) 1.31
Characterization of the regulatory functions of varicella-zoster virus open reading frame 4 gene product. J Virol (1993) 1.30
Efficient formation of a crosslinkable HMT monoadduct at the Kpn I recognition site. Photochem Photobiol (1984) 1.30
Fibronectin promotes rat Schwann cell growth and motility. J Cell Biol (1982) 1.29
Auditory processing in the vegetative state. Brain (2000) 1.28
Regulation of neural markers nestin and GFAP expression by cultivated bone marrow stromal cells. J Cell Sci (2003) 1.28
Protein-binding elements in the promoter region of the mouse p53 gene. Oncogene (1990) 1.27
Vimentin expression in cervical carcinomas: association with invasive and migratory potential. J Pathol (1996) 1.27
Oxidative stress interference with the nuclear factor-kappa B activation pathways. Biochem Pharmacol (2000) 1.25
MDM2: life without p53. Trends Genet (2001) 1.22
Diagnostic and prognostic use of bispectral index in coma, vegetative state and related disorders. Brain Inj (2008) 1.21
An artificial transcription activator mimics the genome-wide properties of the yeast Pdr1 transcription factor. EMBO Rep (2001) 1.21
Communication of preferences for care among human immunodeficiency virus-infected patients. Barriers to informed decisions? Arch Fam Med (1997) 1.21
Molecular analysis of the interaction between an enhancer binding factor and its DNA target. Nucleic Acids Res (1986) 1.19
Varicella-zoster virus induces apoptosis in cell culture. J Gen Virol (1995) 1.15
The ATM protein is required for sustained activation of NF-kappaB following DNA damage. Oncogene (1999) 1.14
Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells. Oncogene (2007) 1.14
Anti-apoptotic activity of low levels of wild-type p53. EMBO J (1996) 1.13
Varicella-zoster virus latency in the adult rat is a useful model for human latent infection. Neurology (1995) 1.13
Assessment of pain in herpes zoster: lessons learned from antiviral trials. Antiviral Res (1997) 1.12
Singlet oxygen-induced mutations in M13 lacZ phage DNA. EMBO J (1987) 1.12
High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer (1996) 1.11
Perceived need for dental care among persons living with acquired immunodeficiency syndrome. Med Care (1991) 1.11
Muscle-specific expression of the acetylcholine receptor alpha-subunit gene requires both positive and negative interactions between myogenic factors, Sp1 and GBF factors. EMBO J (1993) 1.10
Influence of innervation of myogenic factors and acetylcholine receptor alpha-subunit mRNAs. Neuroreport (1991) 1.08
Varicella-zoster virus open reading frame 4 encodes an immediate-early protein with posttranscriptional regulatory properties. J Virol (1997) 1.07
Mutagenesis of the lac promoter region in M13 mp10 phage DNA by 4'-hydroxymethyl-4,5',8-trimethylpsoralen. Proc Natl Acad Sci U S A (1985) 1.07
Cerebral processing in the minimally conscious state. Neurology (2004) 1.06
Regulation of interleukin-6 gene expression by pro-inflammatory cytokines in a colon cancer cell line. Biochem J (2000) 1.05
Comparative immunohistochemical study of herpes simplex and varicella-zoster infections. Virchows Arch A Pathol Anat Histopathol (1993) 1.05
Distinct signal transduction pathways mediate nuclear factor-kappaB induction by IL-1beta in epithelial and lymphoid cells. J Immunol (1997) 1.03
Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63. J Virol (1994) 1.02
Varicella-zoster virus infection of adult rat sensory neurons in vitro. J Virol (1989) 1.02
Transcriptional induction of repair genes during slowing of replication in irradiated Saccharomyces cerevisiae. Mutat Res (2001) 1.02
Spontaneous longitudinally orientated axonal regeneration is associated with the Schwann cell framework within the lesion site following spinal cord compression injury of the rat. J Neurosci Res (1998) 1.02
Neurotrophins affect survival and neuritogenesis by adult injured auditory neurons in vitro. Neuroreport (1994) 1.02
Attitudes towards end-of-life issues in disorders of consciousness: a European survey. J Neurol (2011) 1.01
Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1. Biochem Pharmacol (2000) 1.01
Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsing-remitting multiple sclerosis. Eur J Neurol (2011) 1.01
Effects of neurotrophins on early auditory neurones in cell culture. Neuroreport (1996) 1.00
Radial glia phenotype: origin, regulation, and transdifferentiation. J Neurosci Res (2000) 1.00
Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines. Oncol Res (1998) 1.00
Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin. Blood (2000) 0.99
MicroRNAs tune cerebral cortical neurogenesis. Cell Death Differ (2012) 0.99
New insights into peripherin expression in cochlear neurons. Neuroscience (2007) 0.99
Community-based case management for persons with AIDS. Health Aff (Millwood) (1989) 0.99
Effects of Schwann cell transplantation in a contusion model of rat spinal cord injury. J Neurosci Res (1996) 0.98
Stimulation of glutathione peroxidase activity decreases HIV type 1 activation after oxidative stress. AIDS Res Hum Retroviruses (1994) 0.98